SCHEMBL4751584

SCHEMBL4751584

O=[N+]([O-])c1ccc(CNCCO)c(Br)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.45
▸ TSHR P16473 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA4 P22748 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ CHRM2 P08172 1/20 0.41
▸ CDC25C P30307 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3594118 0.82 GAA (0.49) KMT2ATSHRCA12CA1CA2
SCHEMBL4715997 0.80 ALDH1A1 (0.46) KMT2ATSHRPOLBCA12CA1
SCHEMBL6665984 0.80 TSHR (0.53) KMT2ATSHRPOLBTDP1CYP1A2
SCHEMBL2061985 0.79 ALDH1A1 (0.46) KMT2ATSHRCA12CA1CA2
SCHEMBL14744170 0.79 CYP1A2 (0.47) TSHRPOLBCA1CA2TDP1
SCHEMBL30206593 0.79 CYP1A2 (0.47) TSHRPOLBCA1CA2TDP1
SCHEMBL31267416 0.78 POLB (0.43) KMT2ATSHRPOLBCA12CA1
SCHEMBL15687827 0.75 KMT2A (0.41) KMT2ATSHRPOLBTDP1ALDH1A1
Hydrochloric Acid SCHEMBL7601655 0.75 ALDH1A1 (0.55) KMT2ACA12CA1CA2CA4
SCHEMBL3119525 0.74 CHRM2 (0.70) KMT2ATSHRCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116332910-A 2-aminopyrimidine derivatives as kinase inhibitors, preparation and use thereof 江苏威凯尔医药科技有限公司 2023-06-27 — — CN disclosed
WO-2008144483-A2 AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2008-11-27 — — WO disclosed
WO-2008144483-A2 AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2008-11-27 — — WO disclosed
Send feedback